Wanbury Limited (WANBURY)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
66
-0.75(-1.12%)

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India. The company offers formulations for gynecology, orthopedics, heamatinics, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner purposes approximately under 70 brands. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. Wanbury Limited also exports its products. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.

Pricing Updates

TODAY'S HIGH

67

TODAY'S LOW

65.2

52 WEEK HIGH

112

52 WEEK LOW

55.05

Major Holders

% of Shares Held by
All Insider

60.03%

% of Shares Held by
Institutions

3.87%

% of Float Held by
Institutions

9.68%

Number of Institutions
Holding Shares

1

Company Overview

MARKET CAP

216.73 Cr.

ETERPRISE VALUE

268.17 Cr.

NO. OF SHARES

3.26 Cr.

BOOK VALUE

-7.269

DIV. YIELD

1%

DEBT

73.60 Cr.

GROSS PROFIT

210.89 Cr.

CASH

25.31 Cr.

REVENUE

511.18 Cr.

REVENUE/SHARE

158.675

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments0000
Change To Liabilities64.97 Cr.14.31 Cr.8.55 Cr.29.72 Cr.
Total cashflows from Investing Activities58.65 Lakhs8.04 Cr.63.66 Cr.-3.07 Cr.
Net Borrowings-64.98 Cr.-10.64 Cr.-97.07 Cr.-15.40 Cr.
Total Cash from Financing Activities-25.62 Cr.-17.38 Cr.-107.87 Cr.-26.78 Cr.
Other Liabilities-11.71 Cr.-18.61 Cr.10.43 Cr.2.17 Cr.
Total Assets49.66 Cr.2 Lakhs2.50 Lakhs2.50 Lakhs
Net Income81.47 Cr.-12.60 Cr.64.46 Cr.-24.84 Cr.
Change in Cash12.52 Cr.7.34 Cr.-7.90 Lakhs-12.75 Lakhs
Effect of Exchange Rate0000
Total Cash from Operating Activities37.56 Cr.16.68 Cr.44.13 Cr.29.73 Cr.
Depreciation11.44 Cr.9.54 Cr.9.46 Cr.9.75 Cr.
Other Cashflows from Investing Activities-55.39 Lakhs12.44 Cr.-11.35 Cr.1.62 Cr.
Dividends Paid0000
Change to Inventory-24.87 Cr.-12.59 Cr.7.07 Cr.-6.26 Cr.
Change to Account Receivables-28.09 Cr.13.88 Cr.-5.16 Cr.-13.76 Cr.
Other Cashflows from Financing Activities-10.29 Cr.-6.76 Cr.-10.82 Cr.-11.37 Cr.
Change to Net Income-55.64 Cr.22.53 Cr.-50.91 Cr.32.73 Cr.
Capital Expenditures-9.65 Cr.-4.42 Cr.-7.83 Cr.-4.71 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax81.12 Cr.-12.40 Cr.64.67 Cr.-24.98 Cr.
Minority InterestNoneNoneNoneNone
Net Income25.37 Cr.11.20 Cr.13.87 Cr.6.65 Cr.
Selling General Administrative74.80 Cr.69.23 Cr.79.52 Cr.93.71 Cr.
Gross Profit210.89 Cr.170.27 Cr.181.45 Cr.190.04 Cr.
Ebit25.37 Cr.11.20 Cr.13.87 Cr.6.65 Cr.
Operating Income25.37 Cr.11.20 Cr.13.87 Cr.6.65 Cr.
Other Operating Expenses99.26 Cr.80.07 Cr.78.36 Cr.79.71 Cr.
Interest Expense-20.61 Cr.-23.07 Cr.-32.87 Cr.-39.88 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense-34.62 Lakhs20 Lakhs20.87 Lakhs-13.66 Lakhs
Total Revenue511.18 Cr.392.51 Cr.367.45 Cr.391.37 Cr.
Total Operating Expenses485.81 Cr.381.30 Cr.353.57 Cr.384.72 Cr.
Cost of Revenue300.28 Cr.222.24 Cr.185.99 Cr.201.32 Cr.
Total Other Income Expense Net55.75 Cr.-23.61 Cr.50.79 Cr.-31.63 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.81.47 Cr.-12.60 Cr.64.46 Cr.-24.84 Cr.
Net Income Applicable to Common Shares81.47 Cr.-12.60 Cr.64.46 Cr.-24.84 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets10.13 Lakhs22.75 Lakhs41.29 Lakhs57.65 Lakhs
Capital Surplus060.07 Cr.59.99 Cr.59.50 Cr.
Total Liabilities375.96 Cr.418.75 Cr.395.48 Cr.468.66 Cr.
Stock Holder Equity-23.41 Cr.-156.24 Cr.-143.45 Cr.-209.27 Cr.
Minority Interest0000
Other Liabilities95.71 Cr.60.49 Cr.57.85 Cr.62.82 Cr.
Total Assets352.54 Cr.289.17 Cr.278.69 Cr.286.04 Cr.
Common Stock32.66 Cr.25.01 Cr.24.99 Cr.23.72 Cr.
Retained Earnings0-252.76 Cr.-239.71 Cr.-303.72 Cr.
Other Liabilities12.06 Cr.13.75 Cr.11.56 Cr.10.69 Cr.
Good Will0000
Treasury Stock-56.08 Cr.11.43 Cr.11.27 Cr.11.22 Cr.
Other Assets6.11 Cr.9.49 Cr.7.26 Cr.6.54 Cr.
Cash25.31 Cr.10 Cr.2.66 Cr.2.74 Cr.
Current Liabilities359.77 Cr.328.69 Cr.284.38 Cr.334.93 Cr.
Long Term Asset Charges5.63 Cr.5.63 Cr.3.36 Cr.3.36 Cr.
Short Long Term Debt67.02 Cr.83.60 Cr.57.18 Cr.52.78 Cr.
Other Stockholder Equity-56.08 Cr.11.43 Cr.11.27 Cr.11.22 Cr.
Property Plant Equipment169.35 Cr.178.17 Cr.177.37 Cr.180.75 Cr.
Total Cur. Assets173.20 Cr.101.26 Cr.93.63 Cr.98.15 Cr.
Long Term Investments3.77 Cr.1.32 Lakhs68 k1.98 Lakhs
Net Tangible Assets-23.52 Cr.-156.47 Cr.-143.86 Cr.-209.85 Cr.
Short Term Investments013.01 Lakhs12.03 Cr.0
Net Receivables63.94 Cr.56.68 Cr.55.34 Cr.65.86 Cr.
Long Term Debt071.99 Cr.99.54 Cr.123.03 Cr.
Inventory49.72 Cr.24.85 Cr.12.25 Cr.19.33 Cr.
Accounts Payable191.61 Cr.133.76 Cr.121.86 Cr.112.23 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account